Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang, Na Li, Yu-Lan Cui
Cancer Res Treat. 2020;52(3):798-814.   Published online 2020 Mar 3     DOI: https://doi.org/10.4143/crt.2019.498
Citations to this article as recorded by Crossref logo
USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway
Lipeng Pei, Feng Zhao, Yi Zhang
Apoptosis.2024; 29(1-2): 210.     CrossRef
BIRC5 facilitates cisplatin‐chemoresistance in a m6A‐dependent manner in ovarian cancer
Yadan Fan, Yinglian Pan, Liping Jia, Shuzhen Gu, Binxin Liu, Ziman Mei, Chunyan Lv, Haohao Huang, Genhai Zhu, Qingchun Deng
Cancer Medicine.2024;[Epub]     CrossRef
Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
Shahil Alam, Pankaj Kumar Giri
Cancer Drug Resistance.2024;[Epub]     CrossRef
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
Emine Bayraktar, Recep Bayraktar, Hulya Oztatlici, Gabriel Lopez-Berestein, Paola Amero, Cristian Rodriguez-Aguayo
Non-Coding RNA.2023; 9(2): 27.     CrossRef
Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
Weijia Li, Xibo Zhao, Rujian Zhang, Jiabin Xie, Guangmei Zhang, Jinghua Pan
Mediators of Inflammation.2023; 2023: 1.     CrossRef
Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity
Kaili Cen, Ming Chen, Mengye He, Zhenhao Li, Yinjing Song, Pu Liu, Qi Jiang, Suzhen Xu, Yunlu Jia, Peng Shen
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Gomisin J attenuates cerebral ischemia/reperfusion injury by inducing anti-apoptotic, anti-inflammatory, and antioxidant effects in rats
Xiaoli Min, Linping Zhao, Ying Shi, Jian Wang, Hongling Lv, Xiaoxiao Song, Qunyuan Zhao, Qing Zhao, Rui Jing, Jiayi Hu
Bioengineered.2022; 13(3): 6908.     CrossRef
MicroRNA as a Potential Therapeutic Molecule in Cancer
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Cells.2022; 11(6): 1008.     CrossRef
LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
Chongsheng Xia, Yurui Sun, Yang Li, Junli Ma, Jing Shi
Scientific Reports.2022;[Epub]     CrossRef
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, Yiwen Li, Shouxiang Kuang, Chengcheng Du, Jinyu Zhang, Jianxun Wang, Ying Liu
Frontiers in Oncology.2022;[Epub]     CrossRef
miR-21 Targets Long Noncoding RNA PCAT29 to Promote Cell Proliferation in Neuroblastoma
Zhong Jiang, Xianjun Zhou, Lulu Han, Fujiang Li, Xiwei Hao, Qian Dong, Xin Chen
Critical Reviews in Eukaryotic Gene Expression.2022; 32(8): 1.     CrossRef
Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
Linjiao Chen, Jie Wang, Qian Liu
Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
Yuwen Han, Jun You, Yun Han, Yinglei Liu, Menghui Huang, Xiaoyan Lu, Jingjing Chen, Yanli Zheng
OncoTargets and Therapy.2021; Volume 14: 2711.     CrossRef
LncRNA CCAT1 downregulation increases the radiosensitivity of non‐small cell lung cancer cells
Zhao Wang
The Kaohsiung Journal of Medical Sciences.2021; 37(8): 654.     CrossRef
Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis
Bo Huang, Min Wei, Li Hong
Open Life Sciences.2021; 16(1): 667.     CrossRef
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
Yu-Jie Dong, Wei Feng, Yan Li
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
circ_C20orf11 enhances DDP resistance by inhibiting miR-527/YWHAZ through the promotion of extracellular vesicle-mediated macrophage M2 polarization in ovarian cancer
Jun Yin, Hai-Yan Huang, Ying Long, Yan Ma, Maerkeya Kamalibaike, Reyanguli Dawuti, Li Li
Cancer Biology & Therapy.2021; 22(7-9): 440.     CrossRef
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
Hua Lan, Jing Yuan, Da Zeng, Chu Liu, Xiaohui Guo, Jiahui Yong, Xiangyang Zeng, Songshu Xiao
Frontiers in Genetics.2021;[Epub]     CrossRef
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
Meysam Moghbeli
Journal of Ovarian Research.2021;[Epub]     CrossRef
The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
Gaofeng Li, Jun Gong, Shulong Cao, Zhaoyang Wu, Dong Cheng, Jia Zhu, Xuqun Huang, Jingyi Tang, Yuning Yuan, Wenqi Cai, Haiyuan Zhang
Frontiers in Oncology.2021;[Epub]     CrossRef
Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance
Huimin Lv, Shanshan Jin, Binbin Zou, Yuxiang Liang, Jun Xie, Suhui Wu
Cancer Cell International.2021;[Epub]     CrossRef
Study of Neuronal Apoptosis ceRNA Network in Hippocampal Sclerosis of Human Temporal Lobe Epilepsy by RNA-Seq
Shengkun Yu, Yifei Gu, Tianyu Wang, Long Mu, Haiyang Wang, Shi Yan, Aoweng Wang, Jiabin Wang, Li Liu, Hong Shen, Meng Na, Zhiguo Lin
Frontiers in Neuroscience.2021;[Epub]     CrossRef
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, Vahideh Zarrin, Kiavash Hushmandi, Farid Hashemi, Anuj Kumar, Saeed Samarghandian, Masoud Najafi, Ali Zarrabi
Current Cancer Drug Targets.2021; 21(8): 640.     CrossRef
The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
Martín Salamini-Montemurri, Mónica Lamas-Maceiras, Aida Barreiro-Alonso, Ángel Vizoso-Vázquez, Esther Rodríguez-Belmonte, María Quindós-Varela, María Esperanza Cerdán
Cancers.2020; 12(4): 1020.     CrossRef
Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1
Yun Zhang, Hao Ai, Xue Fan, Suxian Chen, Yadi Wang, Lili Liu
Biological Research.2020;[Epub]     CrossRef
miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6
Yunhe An, Jun Zhang, Xiaoyan Cheng, Baoming Li, Yanjie Tian, Xiaoli Zhang, Fangqi Zhao
Cancer Cell International.2020;[Epub]     CrossRef

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer

Tao Xu, Menglu Dong, Zhi Wang, Hanning Li, Xingrui Li
Cancer Management and Research.2020; Volume 12: 5773.     CrossRef
Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer
Abdelrahman M. Elsayed, Paola Amero, Salama A. Salama, Abdelaziz H. Abdelaziz, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguayo
Cancers.2020; 12(9): 2406.     CrossRef
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
Eleonora A. Braga, Marina V. Fridman, Alexey A. Moscovtsev, Elena A. Filippova, Alexey A. Dmitriev, Nikolay E. Kushlinskii
International Journal of Molecular Sciences.2020; 21(22): 8855.     CrossRef